Teen scientist screens 10 million molecules using AI for dementia research

Myreen Ahsan, a 13-year-old from Friendswood, has completed a significant research project that demonstrates the growing intersection of artificial intelligence and medical science. Using machine learning algorithms, she systematically screened more than 10 million molecular compounds to identify potential therapeutic candidates for frontotemporal dementia, a progressive neurological disorder that affects cognitive function.

The project showcases the practical applications of AI in accelerating drug discovery, a process traditionally requiring extensive laboratory time and resources. By automating the screening process, Ahsan's research methodology has the potential to reduce the time and cost associated with identifying promising drug candidates—a development that could have broader implications for pharmaceutical research.

Her work has earned her selection as a national finalist in a major science competition, reflecting recognition from the scientific community. Ahsan is scheduled to present her findings at a national forum in Washington, D.C. later this year, providing her with an opportunity to share her approach with peers and established researchers.

The achievement highlights how young scientists are increasingly adopting computational methods to tackle complex medical challenges. Frontotemporal dementia, which affects individuals typically in their 40s and 60s, remains a focus of research due to the limited treatment options currently available.